Variant report

Variant	nsv596400
Chromosome Location	chr4:187066640-187092475
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:387)
CpG islands
(count:672)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:387 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:187071057-187071421	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:187082521-187082663	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr4:187090880-187090890	K562	blood:	n/a	n/a
4	BRCA1	chr4:187082411-187082510	GM12878	blood:	n/a	n/a
5	CEBPB	chr4:187078966-187079181	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr4:187067232-187067556	H1-hESC	embryonic stem cell:	n/a	chr4:187067399-187067412
7	CEBPB	chr4:187078958-187079135	IMR90	lung:	n/a	n/a
8	CEBPB	chr4:187089147-187089328	HepG2	liver:	n/a	n/a
9	CEBPB	chr4:187078864-187079223	HepG2	liver:	n/a	n/a
10	CEBPB	chr4:187089187-187089327	A549	lung:	n/a	n/a
11	CEBPB	chr4:187078955-187079103	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr4:187078910-187079176	K562	blood:	n/a	n/a
13	CHD2	chr4:187071137-187071471	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr4:187082399-187082540	HepG2	liver:	n/a	n/a
15	CTCF	chr4:187071247-187071300	Medullo	brain:	n/a	n/a
16	CTCF	chr4:187071137-187071437	GM12878	blood:	n/a	n/a
17	CTCF	chr4:187071203-187071204	LNCaP	prostate:	n/a	n/a
18	CTCF	chr4:187071200-187071350	HCM	heart:	n/a	n/a
19	CTCF	chr4:187071191-187071378	HepG2	liver:	n/a	n/a
20	CTCF	chr4:187080931-187080984	GM12891	blood:	n/a	n/a
21	CTCF	chr4:187071200-187071350	GM12875	blood:	n/a	n/a
22	CTCF	chr4:187071199-187071334	SK-N-SH_RA	brain:	n/a	n/a
23	CTCF	chr4:187091140-187091290	GM12864	blood:	n/a	chr4:187091231-187091240
24	CTCF	chr4:187071205-187071383	LNCaP	prostate:	n/a	n/a
25	CTCF	chr4:187071200-187071350	Hela-S3	cervix:	n/a	n/a
26	CTCF	chr4:187091260-187091279	GM12891	blood:	n/a	n/a
27	CTCF	chr4:187071300-187071450	HFF-Myc	foreskin:	n/a	n/a
28	CTCF	chr4:187091200-187091350	AG04449	skin:	n/a	chr4:187091231-187091240
29	CTCF	chr4:187091200-187091350	HBMEC	blood vessel:	n/a	chr4:187091231-187091240
30	CTCF	chr4:187071097-187071103	GM12891	blood:	n/a	n/a
31	CTCF	chr4:187091160-187091310	HCFaa	heart:	n/a	chr4:187091231-187091240
32	CTCF	chr4:187071180-187071330	AG10803	skin:	n/a	n/a
33	CTCF	chr4:187075193-187075353	HepG2	liver:	n/a	n/a
34	CTCF	chr4:187091160-187091310	GM06990	blood:	n/a	chr4:187091231-187091240
35	CTCF	chr4:187091200-187091350	GM12870	blood:	n/a	chr4:187091231-187091240
36	CTCF	chr4:187071200-187071350	RPTEC	kidney:	n/a	n/a
37	CTCF	chr4:187071220-187071370	GM06990	blood:	n/a	n/a
38	CTCF	chr4:187091160-187091340	HepG2	liver:	n/a	chr4:187091231-187091240
39	CTCF	chr4:187091210-187091345	HepG2	liver:	n/a	chr4:187091231-187091240
40	CTCF	chr4:187079260-187079410	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr4:187091200-187091350	A549	lung:	n/a	chr4:187091231-187091240
42	CTCF	chr4:187091200-187091350	HCT-116	colon:	n/a	chr4:187091231-187091240
43	CTCF	chr4:187079200-187079350	HepG2	liver:	n/a	n/a
44	CTCF	chr4:187091228-187091329	Kidney_OC	kidney:	n/a	chr4:187091231-187091240
45	CTCF	chr4:187071220-187071370	GM12868	blood:	n/a	n/a
46	CTCF	chr4:187071186-187071401	Spleen_OC	spleen:	n/a	n/a
47	CTCF	chr4:187071089-187071424	K562	blood:	n/a	n/a
48	CTCF	chr4:187071220-187071370	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr4:187091140-187091290	GM12873	blood:	n/a	chr4:187091231-187091240
50	CTCF	chr4:187071140-187071290	HAc	cerebellar:	n/a	n/a

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:187070303-187070353	HMEC	breast:	n/a
2	chr4:187070303-187070353	HMEC	breast:	n/a
3	chr4:187069057-187069107	NH-A	brain:	n/a
4	chr4:187090481-187090531	PFSK-1	brain:	n/a
5	chr4:187090536-187090586	SKMC	muscle:	n/a
6	chr4:187070357-187070407	HepG2	liver:	n/a
7	chr4:187090536-187090586	Hepatocyte	liver:	n/a
8	chr4:187071162-187071212	GM19239	blood:	n/a
9	chr4:187078828-187078878	SKMC	muscle:	n/a
10	chr4:187088191-187088241	T-47D	breast:	n/a
11	chr4:187070357-187070407	SK-N-SH_RA	brain:	n/a
12	chr4:187071162-187071212	MCF10A-Er-Src	breast:	n/a
13	chr4:187069057-187069107	SK-N-SH	brain:	n/a
14	chr4:187069057-187069107	HEK293	kidney:	embryo
15	chr4:187090481-187090531	MCF10A-Er-Src	breast:	n/a
16	chr4:187078828-187078878	HRPEpiC	eye:	n/a
17	chr4:187088191-187088241	IMR90	lung:	fetal
18	chr4:187071162-187071212	AG10803	skin:	n/a
19	chr4:187090536-187090586	AoSMC	blood vessel:	n/a
20	chr4:187090536-187090586	AG04450	lung:	fetal
21	chr4:187078771-187078821	NHBE	bronchial:	n/a
22	chr4:187078771-187078821	ovcar-3	ovarian:	n/a
23	chr4:187088169-187088219	SAEC	small airway:	n/a
24	chr4:187078828-187078878	AG04449	skin:	fetal
25	chr4:187071162-187071212	HIPEpiC	eye:	n/a
26	chr4:187070303-187070353	HCPEpiC	choroid plexus:	n/a
27	chr4:187074031-187074081	HepG2	liver:	n/a
28	chr4:187088191-187088241	HPAEpiC	pulmonary alveolar:	n/a
29	chr4:187078771-187078821	GM12878	blood:	n/a
30	chr4:187070303-187070353	T-47D	breast:	n/a
31	chr4:187078828-187078878	Hela-S3	cervix:	n/a
32	chr4:187090536-187090586	GM12878	blood:	n/a
33	chr4:187071162-187071212	NHBE	bronchial:	n/a
34	chr4:187078771-187078821	HCPEpiC	choroid plexus:	n/a
35	chr4:187074031-187074081	U87	brain:	n/a
36	chr4:187078828-187078878	LNCaP	prostate:	n/a
37	chr4:187078771-187078821	AG09319	gingival:	n/a
38	chr4:187088169-187088219	H1-hESC	embryonic stem cell:	embryo
39	chr4:187090536-187090586	Hela-S3	cervix:	n/a
40	chr4:187090536-187090586	LNCaP	prostate:	n/a
41	chr4:187074031-187074081	LNCaP	prostate:	n/a
42	chr4:187071162-187071212	SK-N-MC	brain:	n/a
43	chr4:187078828-187078878	ProgFib	skin:	n/a
44	chr4:187074031-187074081	ProgFib	skin:	n/a
45	chr4:187078771-187078821	HCT-116	colon:	n/a
46	chr4:187070357-187070407	LNCaP	prostate:	n/a
47	chr4:187078771-187078821	HAEpiC	amniotic membrane:	n/a
48	chr4:187090536-187090586	GM12892	blood:	n/a
49	chr4:187071162-187071212	HMEC	breast:	n/a
50	chr4:187069057-187069107	RPTEC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:187083351..187085783-chr4:187086821..187088983,2	K562	blood:
2	chr4:187077276..187078819-chr4:187080715..187083352,2	K562	blood:
3	chr4:187083351..187085783-chr4:187086821..187088983,2	K562	blood:
4	chr4:187080678..187082912-chr4:187084577..187086317,2	K562	blood:
5	chr4:187065362..187066941-chr4:187069127..187071220,2	K562	blood:
6	chr4:187077276..187078819-chr4:187080715..187083352,2	K562	blood:
7	chr4:187065362..187066941-chr4:187069127..187071220,2	K562	blood:
8	chr4:187092198..187094078-chr4:187111646..187113279,2	MCF-7	breast:

No data

Variant related genes	Relation type
FAM149A	TF binding region
ENSG00000250327	TF binding region
ORAOV1P1	TF binding region
FAM149A	CpG island
ENSG00000250327	CpG island
ORAOV1P1	CpG island
ENSG00000269302	chromatin interactions
ENSG00000109794	chromatin interactions
ENSG00000145476	chromatin interactions

Extended variants
information (count: 1332 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:1332 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs876332	chr4:187066640-187066641	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs76864150	chr4:187066648-187066649	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs139470415	chr4:187066672-187066673	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs181364228	chr4:187066682-187066683	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs144300360	chr4:187066686-187066687	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs535634050	chr4:187066699-187066700	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs146576541	chr4:187066776-187066777	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs140852876	chr4:187066786-187066787	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs535018565	chr4:187066801-187066802	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs184367889	chr4:187066834-187066835	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs557836223	chr4:187066851-187066852	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs577080021	chr4:187066898-187066899	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs149715943	chr4:187066912-187066913	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs145654052	chr4:187066932-187066933	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs190597756	chr4:187066965-187066966	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs574237704	chr4:187066970-187066971	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs538562035	chr4:187067153-187067154	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs182321602	chr4:187067206-187067207	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs572001365	chr4:187067215-187067216	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs541043581	chr4:187067235-187067236	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs185991628	chr4:187067237-187067238	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs532928074	chr4:187067290-187067291	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs550092362	chr4:187067314-187067315	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs189314426	chr4:187067322-187067323	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs529487946	chr4:187067403-187067404	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs114453018	chr4:187067482-187067483	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs537643155	chr4:187067508-187067509	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs114167404	chr4:187067522-187067523	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs528540248	chr4:187067549-187067550	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs551836195	chr4:187067571-187067572	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs148908888	chr4:187067603-187067604	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs545452545	chr4:187067639-187067640	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs147001350	chr4:187067687-187067688	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs556536881	chr4:187067712-187067713	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs569927235	chr4:187067741-187067742	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs535651015	chr4:187067808-187067809	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs555573432	chr4:187067828-187067829	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs574253657	chr4:187067837-187067838	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs540805205	chr4:187067838-187067839	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs541780525	chr4:187067844-187067845	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs577614492	chr4:187067863-187067864	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs532559975	chr4:187067898-187067899	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs368615037	chr4:187067900-187067901	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs543007408	chr4:187067908-187067909	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs73027936	chr4:187067911-187067912	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs529515296	chr4:187067920-187067921	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs141956360	chr4:187067960-187067961	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs145902627	chr4:187067972-187067973	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs80013303	chr4:187067978-187067979	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs148215946	chr4:187067993-187067994	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
abnormal development	18461090	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16774939	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	17053054	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Facioscapulohumeral muscular dystrophy	21829175	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17086460	CNVD
Autism	18414403	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:623 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:187065200-187066800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
2	chr4:187065200-187066800	Active TSS	Aorta	Aorta
3	chr4:187065200-187066800	Active TSS	Brain Cingulate Gyrus	brain
4	chr4:187065200-187066800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
5	chr4:187065200-187066800	Active TSS	Esophagus	oesophagus
6	chr4:187065200-187066800	Active TSS	Lung	lung
7	chr4:187065200-187066800	Active TSS	Psoas Muscle	Psoas
8	chr4:187065200-187067000	Active TSS	Brain Substantia Nigra	brain
9	chr4:187065200-187067000	Enhancers	Stomach Mucosa	stomach
10	chr4:187065400-187066800	Active TSS	Left Ventricle	heart
11	chr4:187065400-187067000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chr4:187065400-187067000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
13	chr4:187065600-187066800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
14	chr4:187065600-187066800	Active TSS	Brain Inferior Temporal Lobe	brain
15	chr4:187065600-187066800	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
16	chr4:187065600-187066800	Active TSS	Right Ventricle	heart
17	chr4:187065600-187066800	Active TSS	A549	lung
18	chr4:187065600-187066800	Active TSS	HSMM	muscle
19	chr4:187065600-187066800	Active TSS	NHDF-Ad	bronchial
20	chr4:187065600-187067000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr4:187065600-187079000	Weak transcription	Spleen	Spleen
22	chr4:187066000-187067000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
23	chr4:187066200-187066800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr4:187066200-187066800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr4:187066200-187066800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr4:187066200-187066800	Flanking Active TSS	Pancreas	Pancrea
27	chr4:187066200-187067200	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr4:187066400-187066800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
29	chr4:187066400-187066800	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr4:187066400-187066800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr4:187066400-187066800	Flanking Active TSS	Brain Hippocampus Middle	brain
32	chr4:187066400-187066800	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
33	chr4:187066400-187066800	Flanking Active TSS	Fetal Muscle Leg	muscle
34	chr4:187066400-187066800	Flanking Active TSS	Placenta	Placenta
35	chr4:187066400-187066800	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
36	chr4:187066400-187066800	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
37	chr4:187066400-187066800	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
38	chr4:187066400-187066800	Enhancers	Small Intestine	intestine
39	chr4:187066400-187066800	Flanking Active TSS	NH-A	brain
40	chr4:187066400-187067000	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
41	chr4:187066400-187067000	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr4:187066400-187067000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
43	chr4:187066400-187067000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
44	chr4:187066400-187067000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr4:187066400-187067000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr4:187066400-187067000	Flanking Active TSS	Adipose Nuclei	Adipose
47	chr4:187066400-187067000	Flanking Active TSS	Duodenum Mucosa	Duodenum
48	chr4:187066400-187067000	Flanking Active TSS	Stomach Smooth Muscle	stomach
49	chr4:187066400-187067400	Flanking Active TSS	Liver	Liver
50	chr4:187066400-187067400	Flanking Active TSS	Fetal Brain Male	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links